From RPA Michal Rutkowski

There is also great news from the United Arab Emirates regarding access to modern HAE therapies: Takeda has reached an agreement, and as a result, lanadelumab can be available to all patients with a copayment liability on insurance. The local HAE expert physician must initiate this support patient program.